Streetbeat News

Stock Prices

DHI

Analysts have provided mixed ratings for D.R. Horton (NYSE:DHI) in the last quarter, with 1 bullish, 3 somewhat bullish, 2 indifferent, and 1 somewhat bearish rating. The average 12-month price target among 7 analysts is $135.71, with a high of $166.00 and a low of $116.00. This target has decreased by 3.98% from the previous average of $141.33. Analyst ratings are based on information from company calls, financial statements, and insider conversations, and include predictions on earnings, revenue, and growth, though they are subjective and not infallible.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 12:00 pm

HARP

Harpoon Therapeutics (NASDAQ:HARP) received three bullish analyst ratings in the last quarter with an average price target of $19.33, representing significant upside from the current price of $8.55. This target is a 42.3% decrease from the previous target of $33.50. Analysts base their ratings on various data including company performance and insider conversations.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 12:00 pm

TH

Target Hospitality forecasts its FY24 revenue to be between $410M and $425M, which is below the estimated $456.13M by analysts.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:56 am

TH

Target Hospitality has revised its FY23 revenue guidance downwards from the previous range of $550M - $580M to a new range of $550M - $560M, which is below the estimated $561.7M.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:55 am

APO

WBA

Walgreens Boots Alliance Inc (NASDAQ:WBA) is revisiting the idea of separating from its U.K. drugstore chain, Boots, with a potential valuation of £7 billion. Options include a sale or an IPO in London. The company announced store closures in its Q3 earnings call, aiming to 'optimize' locations. The separation process may start next year, with previous divestiture efforts having been halted in June 2022 due to valuation issues in a tough credit market. Apollo Global Management, Inc. (NYSE:APO) was involved in a previous bid for Boots. Walgreens' strategic focus remains on expanding healthcare services in North America. WBA shares saw a slight increase in premarket trading.

Portfolio Pulse from Vandana Singh

December 13, 2023 | 11:53 am

JNJ

Wells Fargo analyst Larry Biegelsen downgraded Johnson & Johnson (JNJ) from Overweight to Equal-Weight and reduced the price target from $170 to $163.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:52 am

TMHC

Barclays analyst Matthew Bouley has maintained an Equal-Weight rating on Taylor Morrison Home (NYSE:TMHC) and increased the price target from $47 to $55.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:51 am

SKY

Barclays analyst Matthew Bouley has maintained an Equal-Weight rating on Skyline Champion (NYSE:SKY) and increased the price target from $61 to $69.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:50 am

TREX

Barclays analyst Matthew Bouley has downgraded Trex Co (NYSE:TREX), a manufacturer of wood-alternative decking products, from Equal-Weight to Underweight. However, he has increased the price target for the company's stock from $66 to $74.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:49 am

SITE

Barclays analyst Matthew Bouley has maintained an Underweight rating on SiteOne Landscape Supply (NYSE:SITE) but increased the price target from $114 to $121.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:48 am